CClinicalTrials.gg
RecruitingNCT05589220Updated Dec 29, 2025

Study to Evaluate Music Therapy and Nicotine Replacement Therapy on Craving Related to Smoking Cessation in Students

An interventional study of Music Intervention and Nicotine replacement in Smoking Cessation, sponsored by Poitiers University Hospital. Recruiting at 1 site in France. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2025-12-29.

Sponsored by Poitiers University Hospital · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Dec 2022; still recruiting 3 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The study is a randomized, controlled trial comparing music therapy associated to NRT versus NRT alone to evaluate the value of music therapy in improving the management of craving among 120 student smokers (18 to 25 years old). This pilot multi-method study will combine the methodology of clinical trials with qualitative techniques used in social sciences to show the interest of a digital music therapy tool, adapted to a young audience.

Read the detailed description

The participants will be recruited at the Clinical Investigation Center (CIC) of the University Hospital of Poitiers. At baseline visit, they will be randomly 1:1 assigned to receive either music therapy and NRT or NRT alone for 3 months.

During the 3 months after TQD (Target Quit Date), 3 visits will be performed by practitioners at the CIC. Practitioners will register smoking status of the participant, exhaled carbon monoxide concentration, body weight and all adverse events. Participants will answer questionnaires (FTCQ-12, HAD, MNWS, UPPS).

02

Conditions studied

  • Smoking Cessation

Browse trials for

Keywords

  • prevention
  • Music Therapy
  • Craving
03

In context

Smoking Cessation

304 studies on the registry are indexed under Smoking Cessation; 139 are open to participants now.

This study's planned enrollment of 120 is below the median of 154 across 285 interventional studies indexed under Smoking Cessation.

Browse Smoking Cessation studies →

Lead sponsor

Poitiers University Hospital is the lead sponsor of 310 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • students, age >=18 and \<=25 years,
  • smoking more than 5 cigarettes per day for at least 6 months,
  • motivated to quit smoking,
  • without legal tutors or subordination,
  • affiliated to a health insurance system as required by the French law on biomedical research,
  • written informed consent for participation in the study.

Exclusion criteria

Exclusion Criteria:

  • Roommates and couples,
  • NRT contraindication
  • with depression and/or psychosis and/or cognitive disorder and/or mental retardation,
  • substance misuse or alcohol dependence,
  • smoking-cessation medication (NRT, bupropion, varenicline) or undergoing cognitive-behavioral therapy or hypnotherapy in the last 3 months,
  • electronic cigarette for smoking cessation in the last 3 months,
  • Persons benefiting from enhanced protection, i.e. persons deprived of their liberty by a judicial or administrative decision, adults under legal and finally patients in a vital emergency situation.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Music intervention and NRT

    The rhythm of the music sessions will be 2 per week in the first month, 1 per week in the second month and 1 every 15 days in the third month. In this group, music intervention will be associated to NRT.

    Other: Music Intervention · Drug: Nicotine replacement

  • Active comparator
    NRT group

    Nicotine Patch, Nicotine Gum As in the intervention group, the physician will adapt the type of NRT according to the patient's smoking profile.

    Drug: Nicotine replacement

Interventions

  • OtherMusic Intervention

    Music therapy carried out with MUSIC CARE©

  • DrugNicotine replacement

    NRT: Nicotine Patch, Nicotine Gum

06

What researchers measure

Primary outcomes

  1. Assess if Music therapy associated to NRT decrease tobacco craving compared to NRT alone

    Score of French Version of the Tabacco Craving Questionnaire-12 (FTCQ-12). It consist of 12 questions, each rated on a likert-type scale with 7 response options. Lower scores mean a better outcome.

    Time frame: Month 1

Secondary outcomes

  1. Test the feasability of such a program in smoking cessation

    Music therapy sessions compliance. Number and reasons for not attending music thearpy sessions.

    Time frame: Month 3

  2. Evaluate the evolution of tobacco craving

    Score of French Version of the Tabacco Craving Questionnaire-12 (FTCQ-12). It consist of 12 questions, each rated on a likert-type scale with 7 response options. Lower scores mean a better outcome.

    Time frame: Month [2; 3]

  3. Evaluate the evolution of Anxiety

    HAD (Hospital Anxiety and Depression Scale) score. Maximum score for each score (total A, total D) = 21. Score over 10 definites state of anxiety. Lower scores mean a better outcome.

    Time frame: Month [1;2; 3]

  4. Evaluate the evolution of nicotine withdrawal symptoms

    MNWS (Minnesota Nicotine Withdrawal Scale) score. It consist of 8 questions, each rated on a likert-type scale with 0-4 response options. Lower scores mean a better outcome.

    Time frame: Month [1;2; 3]

  5. Evaluate the evolution of impulsivity

    UPPS (Impulsive Behavior Scale) score. It consist of 20 questions, each rated on a likert-type scale with 1-4 response options. Lower scores mean a better outcome.

    Time frame: Month [1;2; 3]

  6. Evaluate the efficacy of the intervention on smoking cessation

    Self reported abstinence or smoking reduction \>or=50%

    Time frame: Month [1;2; 3]

07

Study locations

1 of 1 sites recruiting
  • CHU Poitiers
    Poitiers, 86000, France
    • Claire LAFAY, Dr · Contact
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05589220
Lead sponsor
Poitiers University Hospital
Responsible party
Sponsor
First posted
Oct 21, 2022
Start date
Dec 13, 2022
Primary completion
Jan 2028 (estimated)
Completion
Mar 2028 (estimated)
Last update
Dec 29, 2025

Study contacts

Claire LAFAY-CHEBASSIER, Dr
Contact
claire.lafay-chebassier@chu-poitiers.fr
05 49 44 38 36 ext. 33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion